Cannabis Stocks Drop After Early Surge on Limited US Marijuana Rescheduling Move
Cannabis stocks fell after hype faded: US reform helps medical marijuana only, not full market, so investors took profits.
/ 6 items
#TLRY↓
Trump Administration Set to Reclassify Marijuana This Week
The Trump administration is expected to reclassify marijuana from Schedule I to Schedule III as soon as this week, easing research barriers after months of delay.
BrewDog Sold to Cannabis Giant Tilray in £33m Deal
Craft beer icon BrewDog is being acquired by US cannabis and drinks firm Tilray Brands for around £33 million amid financial struggles. Key assets change hands as the Scottish brewer faces big changes.
Tilray Brands Reports Narrower Q2 Loss Despite Mixed Sales Performance
Tilray (TLRY) narrows Q2 losses to $43.5M with 3% revenue growth driven by cannabis gains, though beverage sales decline 21% amid international expansion strategy.
Trump Orders Move to Reschedule Cannabis, Easing Medical and Business Rules
President Trump signs an executive order to shift cannabis to Schedule III, potentially expanding medical use, research, and business opportunities nationwide.
Trump Signals Major Shift on U.S. Cannabis Policy as Pot Stocks Surge
Cannabis stocks jumped after reports that President Trump may push to reclassify marijuana to Schedule III, easing restrictions and boosting industry prospects.